Mast cell leukemia natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
Line 13: | Line 13: | ||
==Prognosis== | ==Prognosis== | ||
[[Prognosis]] is generally poor, and the median survival time is less than six months.<ref name="Georgin-LavialleLhermitte2012">{{cite journal|last1=Georgin-Lavialle|first1=S.|last2=Lhermitte|first2=L.|last3=Dubreuil|first3=P.|last4=Chandesris|first4=M.-O.|last5=Hermine|first5=O.|last6=Damaj|first6=G.|title=Mast cell leukemia|journal=Blood|volume=121|issue=8|year=2012|pages=1285–1295|issn=0006-4971|doi=10.1182/blood-2012-07-442400}}</ref> | [[Prognosis]] is generally poor, and the median survival time is less than six months.<ref name="Georgin-LavialleLhermitte2012">{{cite journal|last1=Georgin-Lavialle|first1=S.|last2=Lhermitte|first2=L.|last3=Dubreuil|first3=P.|last4=Chandesris|first4=M.-O.|last5=Hermine|first5=O.|last6=Damaj|first6=G.|title=Mast cell leukemia|journal=Blood|volume=121|issue=8|year=2012|pages=1285–1295|issn=0006-4971|doi=10.1182/blood-2012-07-442400}}</ref> | ||
*[[Age|Advanced age]] | *[[Age|Advanced age]] | ||
*[[Weight loss|History of weight loss]] | *[[Weight loss|History of weight loss]] | ||
Line 19: | Line 18: | ||
*[[Thrombocytopenia]] | *[[Thrombocytopenia]] | ||
*[[Hypoalbuminemia]] | *[[Hypoalbuminemia]] | ||
*Excess of bone marrow blasts | *Excess of [[bone marrow]] [[Blast|blasts]] | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 14:07, 23 October 2018
Mast cell leukemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mast cell leukemia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Mast cell leukemia natural history, complications and prognosis |
FDA on Mast cell leukemia natural history, complications and prognosis |
CDC on Mast cell leukemia natural history, complications and prognosis |
Mast cell leukemia natural history, complications and prognosis in the news |
Blogs on Mast cell leukemia natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2], Sogand Goudarzi, MD [3]
Overview
If left untreated, patients with mast cell leukemia may progress to develop weight loss, ascites, and bone abnormalities.[1] Common complications of mast cell leukemia include hepatosplenomegaly, lymphadenopathy, and osteoporosis.[1] Prognosis is generally poor, and the median survival time is less than six months.[2]
Natural History
If left untreated, patients with mast cell leukemia may progress to develop hepatomegaly, splenomegaly, lymph nodes enlargement, bone abnormalities, ascites, and weight loss.[1] Mast cell leukemia is by far an incurable disease with an aggressive behavior.[1]
Complications
Common complications of mast cell leukemia include:[1]
Prognosis
Prognosis is generally poor, and the median survival time is less than six months.[2]
- Advanced age
- History of weight loss
- Anemia
- Thrombocytopenia
- Hypoalbuminemia
- Excess of bone marrow blasts
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Joris, Magalie; Georgin-Lavialle, Sophie; Chandesris, Marie-Olivia; Lhermitte, Ludovic; Claisse, Jean-François; Canioni, Danielle; Hanssens, Katia; Damaj, Gandhi; Hermine, Olivier; Hamidou, Mohammed (2012). "Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive". Case Reports in Hematology. 2012: 1–6. doi:10.1155/2012/517546. ISSN 2090-6560.
- ↑ 2.0 2.1 Georgin-Lavialle, S.; Lhermitte, L.; Dubreuil, P.; Chandesris, M.-O.; Hermine, O.; Damaj, G. (2012). "Mast cell leukemia". Blood. 121 (8): 1285–1295. doi:10.1182/blood-2012-07-442400. ISSN 0006-4971.